Hi Art, Look at this guy background......
ChemTrak names new chief financial officer
BusinessWire, Wednesday, April 16, 1997 at 09:08
SUNNYVALE, Calif.--(BW HealthWire)--April 16, 1997--ChemTrak
Inc. (NASDAQ:CMTR), a full-service personal medical diagnostics
company, Wednesday announced the appointment of Donald V. Fluken as
vice president, finance and chief financial officer.
"We are really pleased to have someone of Mr. Fluken's
experience and caliber join the management team at ChemTrak," said
Edward F. Covell, president and chief executive officer.
Prior to joining ChemTrak, Fluken was vice president and CFO of
Andros Inc., a leading manufacturer of gas analyzers used for medical
and environmental applications, where he was instrumental in leading
a leveraged buyout.
Fluken also served as vice president and CFO of BioGenex
Laboratories, a manufacturer of diagnostic products. He also held
senior financial management positions at Varian Associates, Levi
Strauss and Bell and Howell.
ChemTrak develops and manufactures reliable and easy-to-use
medical testing systems which are designed to screen and diagnose
health conditions with accuracy comparable to physician's office or
laboratory instrumented tests.
Note to Editors: Except for the historical information contained
herein, this news release contains forward-looking statements that
involve risks and uncertainties -- as well as other risks detailed
from time to time in the company's SEC reports, including the report
on Form 10k for the year ended Dec. 31, 1996 and Form 10Q for the
Quarters ended June 30, 1996 and Sept. 30, 1996. Actual results
might differ materially from these statements due to risks and
uncertainties, including determinations by the FDA, the impact of
competitive product and pricing, the timely development and
acceptance of new products and medical market conditions.
CONTACT: ChemTrak Inc., Sunnyvale
Edward F. Covell, 408/773-8156
or
Freeman/McCue Public Relations
714/557-3663 |
